The latest announcement is out from Virpax Pharmaceuticals ( (VRPX) ).
Virpax Pharmaceuticals, Inc. has filed a Form 8-K report with the SEC to announce a significant event that occurred on September 16, 2024. The report details the company’s latest updates, which are essential for shareholders and potential investors tracking the company’s performance. Based in Berwyn, Pennsylvania, Virpax Pharmaceuticals is staying current with its reporting obligations, providing transparency and maintaining investor confidence in the ever-dynamic financial markets.
For an in-depth examination of VRPX stock, go to TipRanks’ Stock Analysis page.
